Back to search results

Genetic and Metabolic Repository for Cerebrovascular Disorders

This study is creating a collection (repository) of samples from people with cerebrovascular diseases, including stroke. Researchers will collect blood, cerebrospinal fluid (CSF - fluid surrounding the brain and spinal cord), tissue, and microdialysis samples. The goal is to use these samples in the future to better understand these conditions, identify markers that predict good or bad outcomes, and track how the disease changes over time or with treatment. This is an observational study, meaning you won't receive a specific intervention as part of the study. You may be eligible if you have been diagnosed with a cerebrovascular disease, are 18 or older, and are willing to provide informed consent.

Study design
This is an observational study planning to enroll up to 900 participants. It is not testing a specific intervention.
What's involved
Not specified in the trial record.
Compensation
Not stated in the trial record.
Follow-up
Your health will be tracked for changes in modified Rankin Scale (mRS) score, NIH Stroke Scale score, and Barthel Index at 1, 3, and 6 months.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT02910180

Genetic, Metabolic, and Growth Factor Repository for Cerebrovascular Disorders

Recruiting
Not specifiedAges 18+Observational
Cedars-Sinai Medical Center
~900 participants
Updated 2023-02-08 on ClinicalTrials.gov

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Change in modified Rankin Scale (mRS) score
Measured over Baseline, 1 Month, 3 Months, and 6 Months
+3 more outcomes measured

Conditions

Cerebrovascular Diseases
Ischemic Stroke
Repository

Explore related trials

AneurysmArteriovenous MalformationCerebrovascular DisorderFistulaIntracranial StenosisIschemic Stroke

Where it's being run

1 sites across 1 states
California1

Study leadership

  • Nestor R Gonzalez, MD, MSCR · PRINCIPAL_INVESTIGATOR · Cedars-Sinai Neurosurgery

Who to contact

Nestor R Gonzalez, MD, MSCR
[email protected]
(310) 423-0783
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

All patients diagnosed with cerebral vascular disease, regardless of gender, age, ethnicity/race, stage of disease or treatment, are eligible.
Expected availability of clinical follow up data
Participants must be willing to provide written, informed consent obtained in accordance with institutional and federal guidelines.

Exclusion

Pregnant women are excluded from the study.

What this trial measures

  • Change in modified Rankin Scale (mRS) scoreBaseline, 1 Month, 3 Months, and 6 Months
  • Change in NIH Stroke Scale scoreBaseline, 1 Month, 3 Months, and 6 Months
  • Change in Barthel IndexBaseline, 1 Month, 3 Months, and 6 Months
  • Change in Montreal Cognitive Assessment test scoreBaseline, 1 Month, 3 Months, and 6 Months